Risultati della ricerca - P. Fustier

130 | TISLELIZUMAB, AN ANTI‐PD‐1 ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: FINAL ANALYSIS FROM THE LYSA PHASE 2 TIRHOL STUDY BGB‐A317‐210 Autoría: H. Ghesquières, K. Bouabdallah, M. André, P. Quittet, C. Borel, A. Stamatoullas Bastard, M. Gilbertson, F. Le Bras, C. Thieblemont, B. Delapierre, M. Touati, P. Feugier, L. Renaud, N. Morineau, T. Gastinne, I. Chaillol, R. Ramchandren, H. Shah, D. Modi, H. Allewelt, P. Fustier, J. Xu, R. Delarue, F. Morschhauser, C. Rossi